Clinical significance of vascular endothelial growth factor in Egyptian colorectal cancer patients

International Journal of Integrative Biology

Volumn 4, Issue 2, 2008, Pages 100-107

  Afify, Mie ^a,c   Samy, Nirvana ^a   Hashim, Maha ^a   Essam, Tarek ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c NONE   (Egypt)

Author keywords

Carbohydrate antigen; Carcinoembryonic antigen (CEA); Colorectal cancer; Vascular endothelial growth factor (VEGF); VEGF isoforms

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; UREA; VASCULOTROPIN;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER STAGING; CANCER TISSUE; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECURRENT DISEASE; UREA BLOOD LEVEL; WESTERN BLOTTING;

EID: 64549125235     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Abou-Zeid AA, Khafagy W, et al. (2002) Colorectal cancer in Egypt. Dis. Colon Rectum. 45(9): 1255-1260.
2. Andre T, Kotelevets L, et al. (2000) Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer 86: 174-181.
3. Am. Joint Committee on Cancer (AJCC): Manual for staging of cancer (4th edn.) J.B. Lippincott Co., Philadelphia, USA, 1992.
4. Bossi P, Viale G, et al. (1995) Angiogenesis in colorectal tumors microvessel quanitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 55:5049-5053.
5. Broll R, Erdmann H, et al. (2001) Vascular endothelial growth factor (VEGF) a valuable serum tumour marker in patients with colorectal cancer. Eur. J. Surg. Oncol. 27:37-42.
6. Cascinu S, Staccioli MP, et al. (2000) Expression of vascular endothelial growth factor can predict event-free survival in Stage II colon cancer. Clin. Cancer Res. 6: 2803-2807.
7. Chieregatti G (1990) The soluble sandwich approach for immunoassays: methodological and instrumental implications. Ann. Biol. Clin. 48: 393-397.
8. Committee on enzymes of the Scandinavian society for the clinical chemistry and clinical physiology (1974) Recommended methods for the determination of four enzymes in blood. Scand. J. Clin. Lab. Invest. 3: 291-309.
9. Committee on enzymes of the Scandinavian society for the clinical chemistry and clinical physiology (1976) Recommended methods for the determination of γ-Glutamyle transferase in blood. Scand. J. Clin. Lab. Invest. 36: 119, 1976.
10. Cressey R, Wattananupong O, et al. (2005) Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumoungenesis. BMC Cancer, 5(128) 1-8.
11. Cubo T, Padilla D, et al. (2004) Serum vascular endothelial growth factor levels in patients with colorectal cancer and its prognostic significance. Med. Clin. (Barc) 122(6): 201-4.
12. El-Bolkainy N, Nouh MA, et al. (2005) Topographic pathology of cancer, third edition, NCI, Cairo, P 1-6, pp. 33-9.
13. El-Eolkainy T, Mona A, et al. (2006) A Comparative Study of Rectal and Colonic Carcinoma: Demographic, Pathologic and TNM Staging Analysis. Journal of the Egyptian Nat. Cancer Inst. 18(3) 258-263.
14. Ellis LM, Takahashi Y, et al. (2000) Vascular endothelial growth factor in human colon cancer biology and therapeutic implications Oncologist 5:11-15.
15. Eissa S, Kenawy G, et al. (2004) Comparison of cytokeratin 20RNA and angiogenin voided urine samples as diagnostic tools for bladder carcinoma. Clinical Biochemistry 37: 803.
16. Grunstein J, Masbad JJ, et al. (2000) Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol. Cell Biol. 20:7222-7291.
17. Henderson R (1993) assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann. Clin. Biochem. 30:512-539.
18. Ingold A.: Single radial immunodiffusion (1933) Scand. J. Immunol. 17:41.
19. Jemal A, Seigel R, et al. (2008) Cancer statistics 2008. CA Cancer J Clin.58:71-96.
20. Khorana A, Alok Charlotte K, et al. (2003) Vascular Endothelial growth Factor, CD68, and Epidermal Growth Factor Receptor Expression and Survival in Patients with Stage II and Stage III Colon Carcinoma. A Role for the Host Response in Prognosis. Cancer 15 (97): 960-968.
21. Kim SB, Fernandes LC, et al. (2003) Assessment of the value of preoperatiwe serum levels of CA 242 and CEA in the Staging and postoperative survival of colorectal adenocarcinoma patients. Int. J. Biol. Markers. 18:182-7.
22. Karayiannakis AJ, Syrigos KN, , et al. (2002) Clinical significance of preoprative serum VEGF levels in patients suffering from colorectal cancer and the effect of tumor surgery. Surgery 131(5): 548-55.
23. Mark L, George y, et al. (2001) VEGF-A, VEGF-C, and VEGF-D in Colorectal Cancer Progression. Neoplacia 3(5), 420-427.
24. Midgley R and Kerr D (1999) Colorectal cancer. Lancet 353: 391-399.
25. Nakayama Y, Sako T, et al. (2002) Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer. Anticancer res. 22:2437-2442.
26. Parkin DM, Bray F, et al. (2001) Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94:153-156.
27. Papetti M and Herman IM (2002) Mechanisms of normal and tumor deroved agiogenesis. Am. J. Physiol. 282: 947-970..
28. Pietra N, Sarli L, et al. (2000) Is tumor angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes? Eur. J. Surg. 166: 552-556.
29. Mancini G, Carbonara AO, et al. (1965) immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry; ??: 2: 235.
30. Magnani JL (2004) The discovery, biology, and drug development of sialyl Lea and sialyl Lex. Arch. Biochem. Biophys. 426: 122-131.
31. Iervolino A, Trisciuoglio D, et al. (2002) Bcl-2 over-expression in human melanonia cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity, Fed. Am. Soc. Eur. Biol. J. 16: 1453-1455.
32. Tsai WS, Inge TH. et al. (2007) Bariatric surgery in adolescents recent national trends in use and in-hospital outcome. Arch. Pediatr. Adolesc. Med. 161(3):217-21.
33. Ratchada C, Onusa W, et al. (2005) Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from Soluble to cell-associated isoform during tumourigenesis. BMC Cancer 5: 128.
34. Sambrook J, Fritsch EF, et al. (1998) Molecular cloning. A laboratory manual, 2nd edition, Cold Spring Harbor (NY), Cold-Spring Harbor Laboratory Press pp 42-59.
35. Skibber JM, Minsky ED, et al. (2001) Cancer of the colon. In DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology. Lippincott Williams & Wilkins, Philadelphia; pp 1216-1270.
36. Soliman A.S, Bondy ML, et al. (1997) Colorectal cancer in Egyptian patients under 40 years of age. Int. J.Cancer 71:26-30.
37. Takahashi Y, Tucker SL, et al. (1997) Vessel count and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch. Surg. 132: 541-546.
38. Tokunaga T, Oshika Y, et al. (1198) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor performance prognosis in colon cancer. Br. J. Cancer 77: 998-1002.
39. Werther K, Christensen IJ, et al. (2002) Colorectal Cancer Study Group. Prognostic impact of matched preoperatiwe plasma and serum VEGF in patients with primary colorectal carcinoma. Br. J. Cancer 86: 417-423.
40. Weichselbaum TE (1946) Quoted from photometric colorimetric Test-Biuret method (Human kit). Amer. J. Clin. Path. 16: 40.
41. Wiley- Liss International Union Against Cancer. UICC TNM Classification of malignant tumors, 6th ed. NY, 2002.
42. Werther K, Sorensen S, et al. (2003) Colorectal Cancer Study Group. Circulating Vascular Endothelial Growth Factor Six Months after Primary Surgery as a Prognostic Marker in Patients with Colorectal Cancer Acta Oncologica 42(8): 837-845.
43. Yoshikawa T, Tsuburaya A, et al. (2000) Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. Cancer Lett. 153:7-12.